x
uploads/warfarin.jpg

warfarin n.1.殺鼠靈,華法令。2.【醫學】華法令阻凝劑〔用華法...

warfighting

Warfarin use has increased since publication during the 1990s of such landmark studies as the stroke prevention in atrial fibrillation ( spaf ) trials , among others , showing that anticoagulation with warfarin could significantly reduce the risk for stroke in patients with af 自從20世紀90年代作為劃時代事件的研究-預防心房心顫病人中風的實驗-發表后華法林應用開始增加,其他的研究也顯示:用抗凝劑能顯著減少心房心顫病人中風的風險。

Conclusions : adjusted - dose warfarin and antiplatelet agents reduce stroke by approximately 60 % and by approximately 20 % , respectiely , in patients who hae atrial fibrillation . warfarin is substantially more efficacious ( by approximately 40 % ) than antiplatelet therapy 結論:在房顫病人中,適量的華法林和抗血小板藥的抗凝治療分別減少了大約60和20的卒中發生率。而實際上,華法林比抗血小板治療更加有效(大約40 ) 。

They also looked at the incidence rates of patients hospitalized with first - ever ischemic cardioembolic stroke in the latter 2 of these periods , to assess the benefit of warfarin , the use of which quadrupled on a per - capita basis between 1988 and 1999 , they note 他們也觀察了最近2個時期曾經第一次因局部缺血性心源性中風住院病人的發病率來評價華法林的好處,華法林應用是1988和1999期間的四倍。

Those who are allergic to eggs , neomycin or a previous dose of influenza vaccine are not suitable to have the influenza vaccination . those with bleeding disorders or on warfarin may receive the vaccine by deep subcutaneous injection 對雞蛋、新酶素( neomycin )或曾經對流感疫苗有過敏反應者,都不宜接受流感疫苗注射。至于本身容易出血的病患者或服用薄血藥人士,可采用皮下注射的方法。

Compared with the control , adjusted - dose warfarin ( 6 trials , 2900 participants ) and antiplatelet agents ( 8 trials , 4876 participants ) reduced stroke by 64 % ( 95 % ci , 49 % to 74 % ) and 22 % ( ci , 6 % to 35 % ) , respectiely 與對照組相比,采用適量的華法林( 6個試驗, 2900名受試者)和抗血小板藥物( 8個試驗, 4876名受試者)抗凝治療的患者卒中發生率分別減少了64和22 。

Warfarin is the most commonly used oral anticoagulant utilized in the united states ( 1 ) , and is often encountered by anesthesiologists in patients with medical conditions requiring chronic anticoagulation or perioperative thromboembolism prophylaxis 華法林是美國最常用的口服抗凝藥物,麻醉醫生也經常遇到需要長期抗凝治療或圍術期預防血栓的患者。

The risk / benefit ratio for warfarin treatment is good when patients are at high risk for stroke but “ narrower “ when used in primary prevention in the elderly , where the benefit may be offset by bleeding risk , they write 在有高風險中風的病人用華法林治療的風險/獲益率很好,但是在老年人預防性應用的風險/獲益率有限,因為出血風險獲益率偏移。

The systemic administration of heparin , warfarin or streptokinase is determined to have a thrombolytic effect but risk systemic or ocular bleeding and appeare to be unhelpul for improving visual acuity 全身應用肝素、華法令或鏈激酶溶栓藥物已被證實對提高視力沒有明確幫助,并且存在全身或局部出血的風險。

Today we will finish our discussion with a very controversial topic : when to pull epidural catheters in patients receiving warfarin or low molecular weight heparin ( lmwh ) prophylaxis 今天我們通過一非常有爭議的話題結束討論:對于接受華發林或lmwh預防性治療的患者什么時候拔除硬膜外導管。

Those who have received influenza vaccination within the last 2 months should also be excluded . individuals with bleeding disorders or on warfarin may receive the vaccine by deep subcutaneous injection 若院友或職員于過往兩個月內已接受過此類疫苗,亦毋須安排注射。

Background : anticoagulants and antiplatelet drugs ( e . g . , warfarin , clopidogrel and acetylsalicylic acid ) are key therapeutic agents in the treatment of cardiovascular diseases 背景:抗凝和抗血小板藥物(如華法令、氯吡格雷、阿司匹林)是治療心血管疾病的主要藥物。

Also examined is the safety of statins in vulnerable groups , such as the elderly , patients who consume excess alcohol or are on warfarin 同時還測試了他汀類藥物在弱勢群體(如老人,過度引酒或正在華法林療法中)的安全性。

She responded well to pulse therapy with methylprednisolone and cyclophosphamide and the administration of warfarin 這位病人對以類固醇及細胞毒殺藥物?主的脈沖治療加上抗凝血藥物使用反應良好。

Warfarin users may need to adjust the amounts of warfarin they take when statin treatment begins and again when it ends 華法林使用者可能在他汀類療法開始后和結束后都重新調整華法林使用量。

Insufficient of treatment with warfarin may be one of the causes of cerebral embolism in the anticoagulant treatment 結論各種原因所致房顫是心源性腦栓塞的主要危險因素,梗死多為大面積。

Other ligands include bilirubin , calcium , hormones , and a ariety of drugs , including aspirin and warfarin 其它配體包括膽紅素、鈣、激素和各種藥物(阿司匹林和華法令) 。

3what drugs alter prothrombin time , but not by changing warfarin levels ( pharmacodynamics ) 3哪些藥物不是通過影響華法林水平而改變凝血酶原時間(藥效動力學角度) ?

2what drugs alter prothrombin time by interacting with warfarin levels ( pharmacokinetics ) 2哪些藥物可通過影響華法林水平改變凝血酶原時間(藥代動力學角度) ?

Are there any studies evaluating the patients receiving chronic warfarin therapy and regional anesthesia 是否有文獻評估接受長期華法林治療和局部麻醉關系?